Category: Include on Menu

Xerox Holdings Corporation (NASDAQ:XRX) posted a strong second-quarter earnings performance that far exceeded Wall Street expectations, although revenue came in slightly below analysts’ forecasts. Investors welcomed the results, sending the company’s shares more than 23% higher in premarket trading on Thursday. The quarter also reflected improving profitability, continued progress integrating Lexmark and further reductions in…

Altria Group Inc. (NYSE:MO) shares fell nearly 4% after the tobacco company reported second-quarter earnings that came in slightly below Wall Street expectations, despite revenue exceeding forecasts. The company also narrowed its full-year earnings guidance, with the midpoint of the updated range falling just below analysts’ projections. Management said it continued to make progress on…

Bristol Myers Squibb (NYSE:BMY) reported second-quarter results that comfortably exceeded Wall Street expectations, driven by continued strength across its growth portfolio. The pharmaceutical company also raised its full-year 2026 financial outlook, sending its shares more than 1% higher in premarket trading on Thursday. The stronger-than-expected performance reflected robust sales of several key medicines, helping offset…

Quanta Services Inc. (NYSE:PWR) delivered better-than-expected second-quarter results, comfortably beating Wall Street forecasts for both revenue and earnings as demand remained robust across its electric infrastructure and underground utility businesses. The strong performance prompted investors to bid the stock sharply higher, with shares climbing more than 12% in premarket trading on Thursday. Revenue and Earnings…

International Paper Company (NYSE:IP) reported second-quarter 2026 results that exceeded earnings expectations, although revenue came in below Wall Street forecasts. Investors responded positively, with the company’s shares rising 1.4% in premarket trading following the announcement. The packaging and paper producer continued to make progress on operational improvements while advancing several strategic projects during the quarter.…

ImmunityBio (NASDAQ:IBRX) shares climbed 7.5% on Thursday after the company announced that the United Arab Emirates had granted marketing approval for ANKTIVA in two cancer indications, further expanding the therapy’s international regulatory reach. The latest authorization broadens the drug’s availability and marks another milestone in ImmunityBio’s global commercialization strategy. UAE Clears ANKTIVA for Two Cancer…

Weekly Unemployment Claims Edge Higher The number of Americans filing for unemployment benefits for the first time increased modestly during the week ended July 25, although new claims remained close to historically low levels, highlighting the continued resilience of the U.S. labour market. According to the Labor Department, initial jobless claims rose by 9,000 to…

Consumer Inflation Cools as PCE Prices Edge Lower U.S. consumer inflation eased in June as the Federal Reserve’s preferred inflation gauge posted its first monthly decline in several months, while separate data showed economic growth lost momentum during the second quarter. Figures released by the Commerce Department showed the personal consumption expenditures (PCE) price index…